Last reviewed · How we verify
NCT03890640
Ultrasound-assisted Thoracic Epidural Catheter Insertion
NA trial testing Ultrasound-guided TECI in Abdominal Neoplasm in 38 participants. Completed in 20 December 2019.
12 December 2019
Quick facts
| Lead sponsor | Asan Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 38 |
| Start date | 4 July 2019 |
| Primary completion | 12 December 2019 |
| Estimated completion | 20 December 2019 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Ultrasound-guided TECI
Conditions studied
- Abdominal Neoplasm — all drugs for Abdominal Neoplasm →
- Thoracic Neoplasm — all drugs for Thoracic Neoplasm →
Sponsor
Asan Medical Center
Who can join
Adults 20 to 79, any sex, with Abdominal Neoplasm or Thoracic Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to access the success rate of ultrasound-guided thoracic epidural catheter insertion, using fluoroscopy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Real-time ultrasound-guided low thoracic epidural catheter placement: technical consideration and fluoroscopic evaluation.
Kim DH, Lee JH, Sim JH, Jeong W, et al · · 2021 · cited 19× · PMID 33893174 · DOI 10.1136/rapm-2021-102578
Verify or expand the search:
- PubMed search for NCT03890640
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abdominal Neoplasm
Currently open trials in the same condition.
- NCT07113808 — Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China · recruiting
- NCT06614179 — A Pan-cancer Screening and Diagnosis Model Based on Abdominal CT Was Established · recruiting
Other Asan Medical Center trials
Trials by the same sponsor.
- NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
- NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
- NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
- NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
- NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03890640 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
- Last refreshed: 18 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03890640.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing